Bulletin
Investor Alert

Horizon Therapeutics PLC

NAS: HZNP

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 20, 2022, 5:20 p.m.

/zigman2/quotes/206690250/composite

$

90.35

Change

0.00 0.00%

Volume

Volume 231,939

Quotes are delayed by 20 min

/zigman2/quotes/206690250/composite

Previous close

$ 89.34

$ 90.35

Change

+1.01 +1.13%

Day low

Day high

$87.88

$90.87

Open

52 week low

52 week high

$82.51

$120.54

Open

Jeffrey W. Sherman

Presently, Jeffrey W. Sherman occupies the position of Chief Medical Officer & Executive Vice President at Horizon Therapeutics Plc and Chief Medical Officer & EVP-Regulatory Affairs at Horizon Therapeutics USA, Inc. (a subsidiary of Horizon Therapeutics Plc). Jeffrey W. Sherman is also on the board of Xeris Biopharma Holdings, Inc. and Governor-Health Section at Biotechnology Innovation Organization and Member-Alumni Board at Feinberg School of Medicine.

In the past Dr. Sherman was Member of American Board of Internal Medicine, Chief Medical Officer & Executive Vice President at NeoPharm, Inc., Chief Medical Officer, SVP-Research & Development at IDM Pharma, Inc., Vice President-Clinical Science at Takeda Global Research & Development Center, Inc., Chief Medical Officer & EVP-Regulatory Affairs at Horizon Pharma, Inc., Head-Oncology Global Medical Operations at Pharmacia Corp., Chief Marketing Officer & Executive Vice President at Hyperion Therapeutics, Inc., President & Director at Drug Information Association, Research Associate at Howard Hughes Medical Institute, Inc. and Member of The National Board of Medical Examiners, Inc.

Dr. Sherman received a doctorate from Chicago Medical School and an undergraduate degree from Lake Forest College.

Transactions

Date Shares Transaction Value
04/06/2022 42,009   Disposition at $110.02 per share. 4,621,831
03/18/2022 8,531   Derivative/Non-derivative trans. at $22.14 per share. 188,876
03/10/2022 8,169   Gift at $0 per share. 0
03/10/2022 8,169   Gift at $0 per share. 0
01/21/2022 2,372   Derivative/Non-derivative trans. at $86.42 per share. 204,989
01/21/2022 5,354   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2022 37,675   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2022 32,301   Award at $0 per share. 0
01/05/2022 52,570   Derivative/Non-derivative trans. at $0 per share. 0
12/13/2021 50   Gift at $0 per share. 0
11/08/2021 10,729   Gift at $0 per share. 0
11/08/2021 10,729   Gift at $0 per share. 0
10/27/2021 10,729   Derivative/Non-derivative trans. at $7.61 per share. 81,647
09/21/2021 46,271   Disposition at $110 per share. 5,089,810
09/21/2021 46,271   Derivative/Non-derivative trans. at $7.61 per share. 352,122
09/03/2021 4,042   Gift at $0 per share. 0
09/03/2021 4,042   Gift at $0 per share. 0
07/28/2021 3,215   Derivative/Non-derivative trans. at $102.5 per share. 329,538
07/28/2021 7,257   Award at $0 per share. 0
07/01/2021 54,789   Disposition at $95 per share. 5,204,955
07/01/2021 5,287   Disposition at $95 per share. 502,265
06/11/2021 5,287   Gift at $0 per share. 0
06/11/2021 5,287   Gift at $0 per share. 0
05/25/2021 12,304   Gift at $0 per share. 0
05/25/2021 12,304   Gift at $0 per share. 0
03/10/2021 66,730   Gift at $0 per share. 0
03/10/2021 66,730   Gift at $0 per share. 0
02/17/2021 871   Derivative/Non-derivative trans. at $87.17 per share. 75,926
02/17/2021 1,965   Award at $0 per share. 0
01/21/2021 2,372   Derivative/Non-derivative trans. at $77.43 per share. 183,664
01/21/2021 5,353   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2021 45,256   Derivative/Non-derivative trans. at $73.28 per share. 3,316,360
01/05/2021 60,313   Award at $0 per share. 0
01/05/2021 41,615   Derivative/Non-derivative trans. at $0 per share. 0
12/29/2020 8,679   Gift at $0 per share. 0
12/29/2020 8,679   Gift at $0 per share. 0
12/08/2020 31,133   Disposition at $71.32 per share. 2,220,406
12/08/2020 9,631   Disposition at $70.6 per share. 679,949
12/07/2020 10,489   Disposition at $72.24 per share. 757,726
12/07/2020 16,200   Disposition at $71.52 per share. 1,158,624
12/07/2020 36,389   Disposition at $70.31 per share. 2,558,511
10/21/2020 13,000   Derivative/Non-derivative trans. at $7.61 per share. 98,930
07/06/2020 9,100   Disposition at $57.5 per share. 523,250
05/11/2020 33,479   Disposition at $45 per share. 1,506,555
05/11/2020 33,479   Derivative/Non-derivative trans. at $4.96 per share. 166,055
03/11/2020 5,287   Derivative/Non-derivative trans. at $12.94 per share. 68,413
03/23/2018 8,528   Derivative/Non-derivative trans. at $13.86 per share. 118,199
03/23/2018 19,250   Derivative/Non-derivative trans. at $0 per share. 0
01/02/2018 7,680   Derivative/Non-derivative trans. at $15.02 per share. 115,354
01/02/2018 15,500   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Timothy P. Walbert
Chairman, President & Chief Executive Officer
Mr. Aaron L. Cox
Chief Financial Officer & Executive Vice President
Dr. Karin Rosen
Chief Scientific Officer
Dr. Elizabeth H. Z. Thompson
Executive Vice President-Research & Development
Dr. Jeffrey W. Sherman
Chief Medical Officer & Executive Vice President
Mr. Michael A. DesJardin
Executive VP-Technical Operations & Quality
Dr. Jeffrey D. Kent
Executive VP-Medical Affairs & Outcomes Research
Mr. Andy Pasternak
Chief Strategy Officer & Executive Vice President
Ms. Holly Copeland
Senior Director-Corporate Social Responsibility
Ms. Marilyn Vetter
Group Vice President-Market Access
Mr. Vikram Karnani
President-International & Executive Vice President
Mr. Miles W. McHugh
Chief Accounting Officer & Senior Vice President
Ms. Tina Ventura
Chief Investor Relations Officer & Senior VP
Ms. Jane Gonnerman
Chief of Staff & Group Vice President-Development
Ms. Irina P. Konstantinovsky
EVP, Chief Human Resources & Diversity Officer
Mr. David Caraher
Secretary
Mr. Sean M. Clayton
Executive Vice President & General Counsel
Dr. Susan Mahony
Independent Director
Mr. Michael G. Grey
Lead Independent Director
Dr. Jeff Himawan
Independent Director
Mr. William Francis Daniel
Independent Director
Ms. Pascale Witz
Independent Director
Dr. James Samuel Shannon
Independent Director
Mr. H. Thomas Watkins
Independent Director
Mr. Gino Santini
Independent Director
Link to MarketWatch's Slice.